Articles by Gary M. Freedman, MD
ACR Appropriateness Criteria® Ductal Carcinoma in Situ
BySeth A. Kaufman, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Manjeet Chadha, MD,Sharon C. Dutton, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Michele Y. Halyard, MD,Kathleen C. Horst, MD,Kristina L. M. Novick, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Jennifer Zook, MD,Bruce G. Haffty, MD Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.
ACR Appropriateness Criteria® Local-Regional Recurrence (LRR) and Salvage Surgery-Breast Cancer
ByMichele Y. Halyard, MD,Eleanor E. R. Harris, MD,Lisa Bailey, MD,Jennifer R. Bellon, MD,Gary M. Freedman, MD,Sharad Goyal, MD,Kathleen C. Horst, MD,Meena S. Moran, MD,Catherine C. Park, MD,W. Warren Suh, MD,Deborah Toppmeyer, MD,Bruce G. Haffty, MD Management recommendations for breast cancer local-regional recurrence (LRR), including patient scenarios, are reviewed, and represent evidence-based data and expert opinion of the American College of Radiology Appropriateness Criteria Expert Panel on LRR.
Approximately 10% to 15% of patients with stage I/II invasive breast cancer will develop a clinically isolated local recurrence. The standard management of an ipsilateral breast tumor recurrence following breast-
